Loss of ceramide production confers resistance to radiation-induced apoptosis. 1997

S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
Department of Pathology, University of Chicago, Pritzker School of Medicine, Illinois 60637, USA.

Ionizing radiation mediates cell death, in part, through chromosomal damage following one or more cell divisions. X-rays also induce programmed cell death (apoptosis) in some cell types both in vitro and in vivo. Both neutral and acidic sphingomyelinases, which generate the lipid second messenger ceramide, are reported to induce apoptosis following ionizing radiation and other death signals such as tumor necrosis factor alpha and Fas ligand. Herein we report that a loss of ceramide production from a neutral sphingomyelinase generates a radioresistant phenotype as measured by a marked decrease in apoptosis. A WEHI-231 subline made deficient in ceramide production was found to be resistant to apoptosis compared with the parental subline following treatment with X-rays. The resistant subline underwent two to three subsequent cell divisions following X-irradiation, confirming that X-rays induce cell death through both mitotic and apoptotic mechanisms. These data suggest that loss of ceramide production following X-rays represents an extranuclear mechanism for the development of radioresistance. Modulation of extranuclear signals may increase tumor cell killing following radiation and represent new cellular targets for cancer therapy.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009829 Oleic Acids A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon. Octadecenoic Acids,Acids, Octadecenoic,Acids, Oleic
D010617 Phenanthridines
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002518 Ceramides Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE. Ceramide
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
April 2014, Oncogene,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
September 2003, Oncogene,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
October 1999, FEBS letters,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
August 1997, Cancer research,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
June 2008, Cancer research,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
January 2021, Neoplasma,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
April 1995, European journal of immunology,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
March 1998, Radiation research,
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
April 2006, Journal of immunology (Baltimore, Md. : 1950),
S J Chmura, and E Nodzenski, and M A Beckett, and D W Kufe, and J Quintans, and R R Weichselbaum
May 2009, The Journal of investigative dermatology,
Copied contents to your clipboard!